Serious Event

Serious Event

Serious Adverse Events (SAEs) are adverse events that result in death, are life-threatening, require or prolong hospitalization, cause persistent or significant disability/incapacity, or are congenital anomalies/birth defects. Each serious event is categorized by term, organ system, assessment type, and source vocabulary to provide standardized reporting across clinical trials.

Serious Event path is as follows:

Study -> Results Section -> Adverse Events Module -> Serious Event

Study -> Results Section -> Adverse Events Module -> Serious Event -> Serious Event Stats

Serious Event


Ignite Creation Date: 2025-12-24 @ 11:08 PM
Ignite Modification Date: 2025-12-25 @ 8:41 PM
NCT ID: NCT00516269
Term: Neutropenic fever
Organ System: Infections and infestations
Assessment Type: SYSTEMATIC_ASSESSMENT
Source Vocabulary: CTCAE (3.0)
Notes: One patient was hospitalized for treatment of neutropenic fever. The patient was on the treatment arm. The serious adverse event (SAE) was not related to study drug. The SAE was related to chemotherapy administration for underlying breast cancer.
Study: NCT00516269
Study Brief: Trial of a Sustained Release Methylphenidate in the Treatment of Fatigue in Cancer Patients
Serious Event Stats (If Any):

Serious Event Stats

Group ID # Events # Affected # At Risk View
EG000 0 0 19 View
EG001 1 1 19 View